Control in rehabilitation research
Introduction
To establish that a treatment has an effect it is necessary to study two groups that differ only in exposure to the variable of interest. Assuming that the outcome differs between the groups, one may conclude logically that it is possession of or exposure to the variable that is the cause of the outcome. This conclusion follows because the effect of every other variable is controlled for. However this logic is only valid if the two groups are otherwise equivalent in their prognosis or natural history, which implies but does not require absolutely that the two groups are equal in relation to all other variables.
In most biomedical research it is always difficult and usually impossible to ensure that all other variables are distributed equally through any selection process. Instead random allocation into groups is used to ensure that the groups are prognostically equivalent (i.e. the net effect of all other variables is more-or-less identical). This approach also overcomes another problem, that of not knowing what factors are actually important in determining prognosis or responsiveness to treatment.
There are still influences that cannot be distributed randomly. These may affect the patient, for example through the interaction with people delivering treatments, through beliefs associated with the allocated treatment, or through interactions with observers collecting data. They may also affect observers. Even if the observers are independent, knowing which group a patient is in influences data recording. 1 Observer bias is usually overcome by ensuring that observers do not know which group a patient is in, so called 'masking' or 'blinding' of outcome assessors, and this is not considered any further.
This editorial will focus on rehabilitation treatments where the effect of interest is an outcome measured at some time after treatment is completed. It will focus on parallel group prospective studies. Similar considerations will apply to other research such as the investigation of the effect of assessments or studies using single case design.
The challenge
The scientific logic requires that a proportion of the study population, selected randomly, is exposed to the intervention and the remainder of the population is not. The only difference between the two populations should be exposure. Logically this could work simply by adding the intervention.
However outcome may be affected other factors associated with the intervention, and simply adding an intervention is an inadequate method for establishing that the added intervention is the sole cause of any effect. These other factors include expectation (of effect), differences in attention given to the patient, being seen by particular professionals, being treated in specific locations and so on.
Thus the challenge is to separate the specific effect of the action of interest from the many non-specific effects associated with the action.
Randomized drug trials
The usual paradigm for a controlled study relates to pharmacological interventions where the variable of interest is an agent that has a pharmacological effect.
The design usually ensures that all patients receive exactly the same management, with the sole exception of the active drug which is systematically only given to a random proportion of all patients. The design is specifically set up to balance the expectations of patients and investigators in relation to the drug.
This leads to the traditional, well-established randomized (to ensure that the groups are equivalent in prognosis), double-blind (to ensure that the expectations of patient, treating teams and observers are equivalent in each group), placebocontrolled (to ensure that expectation is equivalent in each group), parallel (to reduce the influence of any systematic change occurring over time) group design with masked assessors (to reduce bias from expectation in observers) and even masked data analysis (to reduce bias in selecting and interpreting statistical tests).
It is important to remember exactly what is being controlled for in this design. The only different is in the specific biochemical nature of the treatment given. The design otherwise controls for: all aspects of the diagnostic process; the process of explaining the treatment (because neither patient nor doctor know what is being given and so all information covering both options must be given); the process of administering the treatment (usually, even with injections of inactive material); the non-specific influence of any health care professionals involved (time, attention, emotional and practical support, etc.); the specific external features of the treatment (e.g. tablet colour, size, etc.); the process of monitoring treatment, in some instances; the process of collecting research data.
Even in drug trials, establishing full control can be difficult. If the experimental drug requires specific tests to monitor its effectiveness with changes in the dosing schedule, patients and doctors may become aware of the group. Specific, characteristic side-effects may also unblind patients (but not inevitably -the 'nocebo' effect is also powerful). In trials that require close monitoring there may be additional attention from health professionals given to one group.
Thus even in apparently straightforward drug trials, full control of all factors that may influence measured outcome may not be achieved.
Rehabilitation
Rehabilitation usually involves a complicated (i.e. multifactorial) and a (mathematically) complex intervention; mathematical complexity implies that relationships are not necessarily linear or direct. The multifactorial nature of the intervention makes it difficult to establish which particular part(s) of an overall package are crucial, and which less so. It is also difficult to establish which particular parts of a package affect which particular outcomes.
Consequently most studies will, in practice, be evaluating a package or bundle of care and not a single constrained action. Fortunately the concept of bundles of care is becoming accepted, particularly in relation to safety in surgery. 2 Furthermore rehabilitation is delivered into a (mathematically) complex situation where causal relationships are also often non-linear.
Complexity is part of many health care interventions 3 and complexity particularly makes it difficult to confirm causal relationships by looking for a dose-response relationship.
In contrast to a drug trial, it is also impossible to ensure that one group of patients has no rehabilitation interventions whatsoever (i.e. a no treatment group). It would be impractical (and unethical) simply to leave a disabled person without any interaction with any knowledgeable health care professional of any sort. Patients will always receive some intervention (including from friends and others), and it is likely that in many instances much of this activity is similar to the intervention being studied (e.g. giving practical, emotional and informational support, helping the person to learn and practice activities etc.).
Thus all rehabilitation research involves comparing one complicated bundle of care against another. This is true even if the researchers wish to investigate only one part of the bundle. For example evaluation of botulinum toxin as a specific treatment inevitably requires the patient to have additional assessments beforehand and treatments afterwards and most studies will include these within the overall 'bundle' being investigated.
Control
Consequently, in terms of control, there are two components to be considered and controlled.
The first is the effect of all the non-specific aspects of the intervention. These are matters such as quality and quantity of personal attention, assessment procedures, additional specific rehabilitation, time spent practising, etc.
The second is the effect of any expectations generated by the new or otherwise unique intervention. These in turn may also influence time spent practising.
The control patients need, if possible, to be offered an intervention that: 1) Provides an equivalent quantity and quality of non-specific activities. It may be difficult to prove equivalence given that the size and nature of any effects associated with each different associated action will be unknown.
2) Raises an equivalent level of expectation in the patient and, ideally but probably rarely, in the treating therapist or team.
Designing a control intervention that meets these goals will usually be difficult. Controlling for many non-specific features such as extra time or attention, a more detailed assessment protocol, and so on may be relatively easy. Controlling for expectation will be difficult as it is rarely possible to blind patients to the treatment allocated and expectations will vary greatly between patients. One partial solution is to measure expectation. 4 Thus in any randomized trial being reported, it is necessary to specify briefly but systematically how the two groups differed in terms of all interventions received that may have an impact upon the primary outcome measure (distal goal). This will allow others to estimate the amount of control achieved.
A systematic approach, derived from a suggested approach to describing rehabilitation treatment, 5 is shown in Table 1 where six potential domains are given. These will be discussed in more detail.
Theoretical basis
Although all treatments should have some underlying theoretical justification, in reality this is either absent or weak in most cases. It would be particularly difficult to give a full theoretical justification for 'routine practice locally' which is commonly used as a control. Nonetheless a brief explanation of the conceptual underpinning of the new intervention and how this differs from the control intervention should usually be given.
Specific goals
The specific goal of the intervention under investigation should be stated. It would usually be wise to include a measure that identifies whether this proximate variable is in fact altered more in the treated group; this would at least identify whether the treatment had some effect. As above, it will rarely be possible to state any specific proximate goal for the control intervention unless a second specific intervention is used as a control. In most drug trials, the process of 'making the diagnosis' is complete before randomization and it applies equally to both groups. Even in the context of drug trials, there are situations where further particular information is needed to specify the dose or changing dose of treatment; for example how severe is the hypertension, or the infection, or the rheumatoid arthritis?
The diagnostic process
In most rehabilitation trials further diagnosis (assessment) occurs after randomization. For example in a trial comparing an ankle-foot orthosis (AFO) to functional electrical stimulation in people with foot-drop, there would be further assessments after randomization to tailor the particular stimulation parameters or AFO to the patient. It would be difficult and inappropriate to undertake all diagnostic processes for both therapies before randomization.
Thus in rehabilitation trials there will usually be differences in the diagnostic processes associated with the treatments being compared and these need to be mentioned.
Incidental, non-specific interventions
These differences in assessment may in turn lead on to differences in incidental actions. For example the results of an assessment may lead to some specific information being given to the patient 
Specific actions
This is the area where it is likely to be easiest to describe the intervention being investigated, but again it may be difficult to describe the control if it is simply an equivalent time of 'normal practice'. Nonetheless there should be a clear description of all the actions that are unique to patients in the experimental group. This will obviously include the specific treatment being investigated, but is likely to include a range of other actions that are not undertaken in the control group. This latter part is important. Within the last year a paper was submitted to this journal concerning a randomized trial of specific treatment which was well described in the methods. However in the discussion, when considering why differences may have arisen between the groups, the authors mentioned that the team delivering the experimental intervention had additionally encouraged their patients to exercise generally (not the specific treatment being investigated) each time they had been seen; the control group had (by implication) not had such regular and frequent encouragement. Thus in fact two interventions were being examined: the specific therapy and regular reminding to exercise. This was not mentioned in the methods section.
It is also important to consider and describe any additional monitoring of change and/or additional feedback or other actions that arise after the specific intervention, and to consider whether the experimental group has less of some 'routine' intervention given in the control group.
Context
Finally it is important to consider and describe any associated contextual differences. For example one group may receive part of their treatment in a special or different environment, and it is probable that the people giving the experimental treatment have more or different expertise. Being treated as 'special' in itself may alter outcome, and it is important to recognize these differences. Again only the research group can identify these differences.
Conclusion
This Editorial has suggested that in randomized trials there will be systematic differences between the groups in important factors that may influence outcome over and above the intended difference in the factor being investigated. To help identify this so that (a) suitable controls may be put in place and (b) authors can report on differences clearly, a systematic approach to identifying differences between the experiences of groups of patients in controlled clinical trials of rehabilitation has been suggested.
This systematic approach may well be incomplete. Certainly it will be rare that all differences can be identified and listed. Certainly it will be difficult to control for all non-specific differences. Nevertheless the current standard of description of the differences between experimental and control groups in rehabilitation studies (and in many other studies of other health care interventions) can certainly be improved and I hope that this helps. I also hope it helps in evaluating critically both what control can be designed into future studies and what was not controlled for in existing published studies.
